Related Experiment Videos
Sites of control of hepatic cholesterol biosynthesis
Abstract:
An inhibition in the conversion of mevalonate to cholesterol has been demonstrated in liver of cholesterol-fed rats by both in vitro and in vivo methods. Synthesis decreased to 30% of the control value after 1 week and 20% after 1 month on a 1% cholesterol diet. After a year, synthesis from mevalonate was almost completely inhibited. The rate of conversion of squalene to cholesterol was not consistently decreased but that of farnesyl pyrophosphate to cholesterol was decreased considerably. The rate of conversion of mevalonate to farnesyl pyrophosphate by a soluble liver enzyme preparation was also decreased in cholesterol-fed animals. Sites of inhibition of cholesterol synthesis were detected before mevalonate, between mevalonate and farnesyl pyrophosphate, and after farnesyl pyrophosphate, probably at the conversion of farnesyl pyrophosphate to squalene. The inhibition of mevalonate conversion to cholesterol developed more slowly than that of acetate and appeared to be secondary to it. The maximum capacities of normal liver homogenates and slices to synthesize cholesterol from mevalonate were shown to be far greater than from acetate. Consequently, sites of inhibition after mevalonate probably do not have a significant effect on the over-all rate of cholesterol synthesis in the intact cholesterol-fed animal.
Insights
Dietary cholesterol significantly inhibits cholesterol synthesis in rat liver, primarily affecting the conversion of mevalonate to cholesterol. This inhibition develops gradually, impacting key enzymes in the cholesterol biosynthesis pathway.
Area of Science:
- Biochemistry
- Metabolic Research
Background:
- Cholesterol homeostasis is crucial for cellular function.
- Dietary cholesterol intake can influence endogenous cholesterol synthesis.
- Understanding the regulation of cholesterol biosynthesis is vital for metabolic health.
Purpose of the Study:
- To investigate the impact of a high-cholesterol diet on cholesterol synthesis in rat liver.
- To identify specific sites of inhibition within the cholesterol biosynthesis pathway.
Main Methods:
- In vitro and in vivo studies using liver tissue from cholesterol-fed rats.
- Measurement of cholesterol synthesis rates from various precursors, including mevalonate and acetate.
- Enzyme assays to assess conversion rates between intermediates.
Main Results:
- Significant inhibition of mevalonate to cholesterol conversion observed, decreasing to 20% after one month and nearly complete inhibition after one year.
- Inhibition was noted at multiple steps, including between mevalonate and farnesyl pyrophosphate, and potentially farnesyl pyrophosphate to squalene.
- The conversion of acetate to cholesterol was inhibited more rapidly than mevalonate conversion, suggesting secondary inhibition.
Conclusions:
- High dietary cholesterol profoundly inhibits hepatic cholesterol synthesis, primarily impacting the mevalonate pathway.
- The observed inhibition is a complex process affecting multiple enzymatic steps.
- While multiple inhibition sites exist, the primary bottleneck appears to be upstream of farnesyl pyrophosphate conversion.